data_1d8z_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1d8z _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.38 -0.6 . . . . 7.46 109.38 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -68.6 120.19 14.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.93 . . . . 5.46 109.43 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 55' ' ' PRO . 23.3 t -159.07 -48.8 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.237 -0.915 . . . . 4.0 109.617 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 61.75 89.79 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.852 . . . . 4.25 109.492 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.412 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 16.7 p -118.4 71.48 0.84 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 1.93 109.43 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 80' ' ' ALA . 5.2 p30 -125.01 113.68 18.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 1.79 109.733 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.533 ' CD1' HD13 ' A' ' 62' ' ' ILE . 3.1 mm? -135.83 89.36 2.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.381 -0.824 . . . . 1.17 109.338 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 7' ' ' ILE . 6.1 tt -92.75 127.52 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.052 -1.03 . . . . 1.24 109.305 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.509 HG22 ' CZ ' ' A' ' 24' ' ' PHE . 21.9 t -101.27 152.05 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.321 -0.862 . . . . 1.19 109.418 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.8 OUTLIER -145.38 176.63 9.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.127 -0.983 . . . . 1.96 109.438 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.497 ' HB3' ' HA ' ' A' ' 75' ' ' ILE . 53.0 m-85 61.15 43.77 10.75 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.332 -0.855 . . . . 2.28 109.608 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.475 HD13 ' N ' ' A' ' 48' ' ' GLY . 26.5 mt -80.11 137.96 53.01 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.922 . . . . 1.29 109.462 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' A' ' 15' ' ' MET . 35.9 Cg_endo -78.76 157.63 27.86 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.559 2.173 . . . . 0.8 110.428 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.469 ' NE2' ' HE2' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -45.36 -69.74 0.12 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.235 -0.915 . . . . 3.04 110.198 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.48 ' OD1' ' OE2' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -38.71 -48.14 1.45 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.341 -0.849 . . . . 1.86 110.715 -178.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.549 ' CA ' ' OE2' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -49.25 135.51 16.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.952 -1.093 . . . . 1.51 109.554 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.536 ' CG2' ' OD2' ' A' ' 18' ' ' ASP . 5.8 t -157.89 -154.79 0.46 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.349 -0.982 . . . . 1.29 108.349 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.403 ' N ' ' CG2' ' A' ' 16' ' ' THR . 9.2 tt0 -67.1 -30.32 70.31 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.754 -1.216 . . . . 2.9 110.128 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.536 ' OD2' ' CG2' ' A' ' 16' ' ' THR . 0.9 OUTLIER -84.5 -47.12 10.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.98 -1.075 . . . . 1.28 109.896 -179.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.549 ' OE2' ' CA ' ' A' ' 15' ' ' MET . 6.5 tt0 -71.99 -15.52 62.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.025 -1.047 . . . . 1.59 109.265 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.566 ' CZ ' HG21 ' A' ' 50' ' ' VAL . 13.5 t80 -86.66 -31.8 20.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.158 -0.964 . . . . 2.09 108.913 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -70.04 -54.16 14.38 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.453 -0.779 . . . . 2.85 109.639 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 p -61.76 -44.81 96.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.247 -0.908 . . . . 1.54 109.906 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.579 HD12 ' CD1' ' A' ' 24' ' ' PHE . 1.4 tm? -48.45 -66.96 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -0.937 . . . . 1.44 109.716 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.579 ' CD1' HD12 ' A' ' 23' ' ' LEU . 28.3 m-85 -84.38 6.23 24.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.175 -0.953 . . . . 2.19 109.73 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.11 -36.66 12.53 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.794 -1.322 . . . . 0.49 109.794 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.7 m -90.02 42.64 1.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -1.202 . . . . 2.05 109.662 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.543 ' CD1' ' CD1' ' A' ' 65' ' ' LEU . 13.0 mt -141.2 -39.08 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 1.62 109.514 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -163.56 162.11 34.69 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.75 -1.34 . . . . 1.02 109.75 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 31' ' ' GLU . 10.3 t70 -74.04 83.11 1.76 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.294 -1.121 . . . . 2.21 109.582 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.55 ' CG2' ' SG ' ' A' ' 33' ' ' CYS . 13.4 mt -55.11 90.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.197 -0.94 . . . . 1.27 109.156 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 29' ' ' ASP . 6.4 mm-40 -37.11 -29.66 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.787 -0.57 . . . . 2.34 110.134 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 30' ' ' ILE . 0.6 OUTLIER -172.65 115.7 0.3 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.126 -0.984 . . . . 1.82 109.807 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.55 ' SG ' ' CG2' ' A' ' 30' ' ' ILE . 3.8 m -89.36 171.94 9.38 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.324 -0.86 . . . . 1.4 108.699 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.41 71.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.01 -1.057 . . . . 3.06 109.983 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.572 ' CD2' ' N ' ' A' ' 36' ' ' VAL . 7.2 tt -68.78 152.32 45.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 1.56 109.619 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.621 ' CG2' ' CZ ' ' A' ' 47' ' ' TYR . 54.2 t -68.02 126.06 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 1.18 109.479 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 38' ' ' ASP . 3.2 tpt85 -149.58 93.99 2.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 5.7 109.445 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -43.71 161.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 3.19 109.496 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.71 20.35 18.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.896 . . . . 6.42 109.419 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.8 mt -111.72 -91.65 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.867 . . . . 4.82 109.326 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' A' ' 42' ' ' GLY . 5.7 t -77.87 -46.75 20.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.225 -0.922 . . . . 6.68 109.104 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.555 ' N ' ' CG2' ' A' ' 41' ' ' THR . . . 116.88 28.56 2.43 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.681 -1.368 . . . . 4.26 109.681 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.34 136.37 36.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -1.153 . . . . 6.04 109.518 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.8 p -79.31 146.79 32.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.887 . . . . 3.95 109.538 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.521 ' CG ' HG12 ' A' ' 36' ' ' VAL . 15.8 mt -85.37 -3.27 58.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -0.878 . . . . 2.27 109.828 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 47' ' ' TYR . . . 87.63 32.34 13.52 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.91 -1.276 . . . . 1.02 109.91 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.621 ' CZ ' ' CG2' ' A' ' 36' ' ' VAL . 10.3 p90 -179.09 143.56 0.21 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.238 -1.154 . . . . 2.32 109.339 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.475 ' N ' HD13 ' A' ' 11' ' ' LEU . . . -129.03 178.95 16.98 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.076 -1.21 . . . . 0.66 110.076 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -121.23 142.68 49.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.382 -1.069 . . . . 2.31 109.134 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.566 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 32.3 t -144.16 142.09 24.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.119 -0.988 . . . . 1.16 109.657 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -129.27 113.34 14.89 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.751 -0.833 . . . . 2.33 108.751 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.412 ' O ' ' CG2' ' A' ' 4' ' ' THR . 3.5 m-30 -79.01 177.42 8.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.135 -0.978 . . . . 2.08 109.398 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 t -89.76 -32.58 16.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 1.75 109.54 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.45 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 1.0 OUTLIER -129.17 161.77 56.36 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 1.9 109.5 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 54' ' ' ASP . 35.1 Cg_endo -76.78 -21.05 12.96 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.659 2.239 . . . . 0.81 110.467 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.468 ' HA ' ' OD2' ' A' ' 59' ' ' ASP . 7.6 m120 -75.57 -42.36 52.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.306 -0.871 . . . . 1.97 109.293 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -73.49 -24.59 60.2 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.374 -0.829 . . . . 1.98 109.042 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.442 ' CB ' HD22 ' A' ' 6' ' ' LEU . . . -77.32 -41.3 41.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.359 -0.838 . . . . 1.09 109.311 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 17.4 p30 -69.68 -20.77 63.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.166 -0.959 . . . . 1.22 109.291 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.534 ' HG3' ' N ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -79.29 -38.47 35.29 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.139 -0.975 . . . . 2.47 108.548 179.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.534 ' N ' ' HG3' ' A' ' 60' ' ' LYS . . . -65.94 -21.66 66.44 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.08 -1.012 . . . . 1.23 108.305 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.578 HD11 ' CE2' ' A' ' 79' ' ' TYR . 49.5 mt -92.86 -27.18 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.541 -0.724 . . . . 1.14 109.378 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.487 ' OD1' ' O ' ' A' ' 60' ' ' LYS . 0.9 OUTLIER -81.11 2.61 26.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.898 -1.126 . . . . 1.59 109.537 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.7 m -133.29 -31.58 1.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 1.95 110.118 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.543 ' CD1' ' CD1' ' A' ' 27' ' ' ILE . 1.1 mt -106.9 8.19 30.49 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.047 -1.033 . . . . 1.82 110.021 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 62' ' ' ILE . 16.4 t-20 -83.18 85.78 7.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.913 -1.117 . . . . 2.14 109.408 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.542 ' HA2' ' CG ' ' A' ' 76' ' ' LYS . . . 108.8 57.85 0.55 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.123 -1.591 . . . . 0.65 109.123 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.584 ' HB2' ' CG2' ' A' ' 75' ' ' ILE . 2.3 mt -90.44 135.76 33.49 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.183 -1.186 . . . . 1.31 108.672 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -90.83 148.23 22.65 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.921 -1.112 . . . . 3.63 110.043 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.448 ' CD1' HG22 ' A' ' 75' ' ' ILE . 3.9 mt -123.14 174.12 7.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.417 -0.802 . . . . 1.97 109.256 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.426 ' C ' HG21 ' A' ' 72' ' ' THR . 9.3 tt0 -56.39 -32.49 64.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 4.05 109.786 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.426 HG21 ' C ' ' A' ' 71' ' ' GLN . 73.7 p -154.56 21.42 0.47 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.172 -0.955 . . . . 2.22 109.914 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.469 ' HE2' ' NE2' ' A' ' 13' ' ' GLN . 6.5 mttp -142.84 170.63 15.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.126 -0.984 . . . . 3.57 109.504 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.2 m -129.42 108.19 10.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.198 -0.939 . . . . 1.26 109.53 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.584 ' CG2' ' HB2' ' A' ' 68' ' ' LEU . 0.9 OUTLIER -89.43 158.9 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.589 -0.893 . . . . 1.9 108.589 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.542 ' CG ' ' HA2' ' A' ' 67' ' ' GLY . 4.2 mtpt -160.84 130.92 5.08 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.106 -1.038 . . . . 2.34 110.908 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 65' ' ' LEU . 85.7 t -84.75 160.75 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.533 -0.729 . . . . 1.13 109.055 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.476 ' N ' HG11 ' A' ' 77' ' ' VAL . 68.3 m -160.41 138.14 9.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.132 -0.98 . . . . 1.5 109.817 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.578 ' CE2' HD11 ' A' ' 62' ' ' ILE . 45.6 m-85 -57.69 129.39 41.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.241 -0.912 . . . . 2.38 109.205 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.462 ' HA ' ' CG2' ' A' ' 7' ' ' ILE . . . -70.04 106.98 3.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.244 -0.91 . . . . 1.31 109.954 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.469 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -121.68 159.7 49.71 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.829 . . . . 7.57 109.144 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 81' ' ' ARG . 35.6 Cg_endo -77.56 170.59 18.98 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.579 2.186 . . . . 4.92 110.441 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.1 t -48.7 161.05 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 5.89 109.386 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.42 -32.6 73.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.281 -0.887 . . . . 6.57 109.368 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . 67.58 62.82 0.43 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 6.8 109.519 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.441 ' O ' HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -85.25 -173.49 4.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.184 -0.947 . . . . 7.92 109.251 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.441 HD12 ' O ' ' A' ' 86' ' ' SER . 38.7 mm -142.9 -62.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.257 -0.902 . . . . 9.39 109.455 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.003 -0.999 . . . . 9.59 109.392 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.38 -0.6 . . . . 7.14 109.38 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -68.6 120.19 14.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.93 . . . . 5.46 109.43 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 55' ' ' PRO . 23.3 t -159.07 -48.8 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.237 -0.915 . . . . 3.49 109.617 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 61.75 89.79 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.852 . . . . 3.89 109.492 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.412 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 16.7 p -118.4 71.48 0.84 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 1.93 109.43 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.857 ' C ' HD22 ' A' ' 6' ' ' LEU . 5.2 p30 -125.01 113.68 18.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 1.28 109.733 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.014 HD21 ' HB1' ' A' ' 58' ' ' ALA . 3.1 mm? -135.83 89.36 2.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.381 -0.824 . . . . 0.8 109.338 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.62 HD12 ' HE1' ' A' ' 49' ' ' PHE . 6.1 tt -92.75 127.52 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.052 -1.03 . . . . 0.56 109.305 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.543 HG12 HD21 ' A' ' 11' ' ' LEU . 21.9 t -101.27 152.05 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.321 -0.862 . . . . 0.45 109.418 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.6 OUTLIER -145.38 176.63 9.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.127 -0.983 . . . . 1.96 109.438 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 75' ' ' ILE . 53.0 m-85 61.15 43.77 10.75 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.332 -0.855 . . . . 1.4 109.608 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.543 HD21 HG12 ' A' ' 8' ' ' VAL . 26.5 mt -80.11 137.96 53.01 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.922 . . . . 0.56 109.462 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 15' ' ' MET . 35.9 Cg_endo -78.76 157.63 27.86 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.559 2.173 . . . . 0.7 110.428 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.441 ' O ' ' C ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -45.36 -69.74 0.12 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.235 -0.915 . . . . 2.54 110.198 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.63 ' ND2' ' OE2' ' A' ' 19' ' ' GLU . 15.3 p-10 -38.71 -48.14 1.45 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.341 -0.849 . . . . 1.42 110.715 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.549 ' CA ' ' OE2' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -49.25 135.51 16.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.952 -1.093 . . . . 1.06 109.554 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.794 HG23 ' H ' ' A' ' 18' ' ' ASP . 5.8 t -157.89 -154.79 0.46 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.349 -0.982 . . . . 0.68 108.349 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.625 ' N ' HG23 ' A' ' 16' ' ' THR . 9.2 tt0 -67.1 -30.32 70.31 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.754 -1.216 . . . . 2.51 110.128 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.794 ' H ' HG23 ' A' ' 16' ' ' THR . 0.9 OUTLIER -84.5 -47.12 10.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.98 -1.075 . . . . 1.28 109.896 -179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.63 ' OE2' ' ND2' ' A' ' 14' ' ' ASN . 6.5 tt0 -71.99 -15.52 62.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.025 -1.047 . . . . 1.59 109.265 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.639 ' HB2' HD12 ' A' ' 35' ' ' LEU . 13.5 t80 -86.66 -31.8 20.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.158 -0.964 . . . . 1.21 108.913 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -70.04 -54.16 14.38 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.453 -0.779 . . . . 2.4 109.639 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 p -61.76 -44.81 96.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.247 -0.908 . . . . 1.2 109.906 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.783 HD12 ' CD1' ' A' ' 24' ' ' PHE . 1.4 tm? -48.45 -66.96 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -0.937 . . . . 0.8 109.716 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.783 ' CD1' HD12 ' A' ' 23' ' ' LEU . 28.3 m-85 -84.38 6.23 24.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.175 -0.953 . . . . 1.26 109.73 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.11 -36.66 12.53 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.794 -1.322 . . . . 0.49 109.794 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.7 m -90.02 42.64 1.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -1.202 . . . . 1.68 109.662 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 1.01 ' CD1' HD11 ' A' ' 65' ' ' LEU . 13.0 mt -141.2 -39.08 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 0.93 109.514 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -163.56 162.11 34.69 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.75 -1.34 . . . . 0.84 109.75 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 31' ' ' GLU . 10.3 t70 -74.04 83.11 1.76 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.294 -1.121 . . . . 2.21 109.582 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.743 HG21 ' SG ' ' A' ' 33' ' ' CYS . 13.4 mt -55.11 90.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.197 -0.94 . . . . 0.64 109.156 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 29' ' ' ASP . 6.4 mm-40 -37.11 -29.66 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.787 -0.57 . . . . 2.34 110.134 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 30' ' ' ILE . 0.6 OUTLIER -172.65 115.7 0.3 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.126 -0.984 . . . . 1.45 109.807 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.743 ' SG ' HG21 ' A' ' 30' ' ' ILE . 3.8 m -89.36 171.94 9.38 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.324 -0.86 . . . . 0.85 108.699 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.41 71.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.01 -1.057 . . . . 2.59 109.983 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 1.043 HD23 ' N ' ' A' ' 36' ' ' VAL . 7.2 tt -68.78 152.32 45.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.95 109.619 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.043 ' N ' HD23 ' A' ' 35' ' ' LEU . 54.2 t -68.02 126.06 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.83 109.479 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 38' ' ' ASP . 3.2 tpt85 -149.58 93.99 2.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 4.91 109.445 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -43.71 161.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 3.19 109.496 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.71 20.35 18.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.896 . . . . 6.06 109.419 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 41' ' ' THR . 39.8 mt -111.72 -91.65 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.867 . . . . 4.66 109.326 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.562 HG23 ' N ' ' A' ' 42' ' ' GLY . 5.7 t -77.87 -46.75 20.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.225 -0.922 . . . . 6.18 109.104 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.562 ' N ' HG23 ' A' ' 41' ' ' THR . . . 116.88 28.56 2.43 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.681 -1.368 . . . . 3.99 109.681 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.34 136.37 36.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -1.153 . . . . 5.77 109.518 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.8 p -79.31 146.79 32.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.887 . . . . 3.48 109.538 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.861 HD12 HG11 ' A' ' 36' ' ' VAL . 15.8 mt -85.37 -3.27 58.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -0.878 . . . . 1.64 109.828 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 47' ' ' TYR . . . 87.63 32.34 13.52 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.91 -1.276 . . . . 0.56 109.91 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.923 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 10.3 p90 -179.09 143.56 0.21 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.238 -1.154 . . . . 1.43 109.339 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.445 ' CA ' ' HA ' ' A' ' 35' ' ' LEU . . . -129.03 178.95 16.98 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.076 -1.21 . . . . 0.66 110.076 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.62 ' HE1' HD12 ' A' ' 7' ' ' ILE . 28.4 m-85 -121.23 142.68 49.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.382 -1.069 . . . . 1.43 109.134 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.645 HG13 HG23 ' A' ' 30' ' ' ILE . 32.3 t -144.16 142.09 24.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.119 -0.988 . . . . 0.5 109.657 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -129.27 113.34 14.89 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.751 -0.833 . . . . 2.07 108.751 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.627 ' HE1' HG11 ' A' ' 50' ' ' VAL . 3.5 m-30 -79.01 177.42 8.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.135 -0.978 . . . . 1.23 109.398 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 t -89.76 -32.58 16.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 1.38 109.54 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.483 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 1.0 OUTLIER -129.17 161.77 56.36 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 1.9 109.5 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 54' ' ' ASP . 35.1 Cg_endo -76.78 -21.05 12.96 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.659 2.239 . . . . 0.72 110.467 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.478 ' HA ' ' OD2' ' A' ' 59' ' ' ASP . 34.7 m-20 -75.57 -42.36 52.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.306 -0.871 . . . . 1.86 109.293 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -73.49 -24.59 60.2 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.374 -0.829 . . . . 1.98 109.042 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 1.014 ' HB1' HD21 ' A' ' 6' ' ' LEU . . . -77.32 -41.3 41.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.359 -0.838 . . . . 0.4 109.311 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 17.4 p30 -69.68 -20.77 63.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.166 -0.959 . . . . 1.22 109.291 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.525 ' HG3' ' N ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -79.29 -38.47 35.29 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.139 -0.975 . . . . 1.87 108.548 179.504 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.735 ' O ' HD12 ' A' ' 65' ' ' LEU . . . -65.94 -21.66 66.44 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.08 -1.012 . . . . 0.54 108.305 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.687 HD13 ' CE2' ' A' ' 79' ' ' TYR . 49.5 mt -92.86 -27.18 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.541 -0.724 . . . . 0.43 109.378 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.508 ' OD1' ' HA ' ' A' ' 60' ' ' LYS . 0.9 OUTLIER -81.11 2.61 26.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.898 -1.126 . . . . 1.56 109.537 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.7 m -133.29 -31.58 1.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 1.52 110.118 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.01 HD11 ' CD1' ' A' ' 27' ' ' ILE . 1.1 mt -106.9 8.19 30.49 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.047 -1.033 . . . . 1.17 110.021 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 62' ' ' ILE . 16.4 t-20 -83.18 85.78 7.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.913 -1.117 . . . . 1.81 109.408 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.547 ' HA2' ' CG ' ' A' ' 76' ' ' LYS . . . 108.8 57.85 0.55 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.123 -1.591 . . . . 0.65 109.123 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.931 ' HB2' HG23 ' A' ' 75' ' ' ILE . 2.3 mt -90.44 135.76 33.49 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.183 -1.186 . . . . 0.75 108.672 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -90.83 148.23 22.65 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.921 -1.112 . . . . 3.2 110.043 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 73' ' ' LYS . 3.9 mt -123.14 174.12 7.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.417 -0.802 . . . . 1.53 109.256 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.441 ' C ' HG23 ' A' ' 72' ' ' THR . 49.7 tt0 -56.39 -32.49 64.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 3.43 109.786 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.441 HG23 ' C ' ' A' ' 71' ' ' GLN . 73.7 p -154.56 21.42 0.47 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.172 -0.955 . . . . 1.85 109.914 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 72' ' ' THR . 6.5 mttp -142.84 170.63 15.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.126 -0.984 . . . . 3.18 109.504 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.2 m -129.42 108.19 10.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.198 -0.939 . . . . 0.83 109.53 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.931 HG23 ' HB2' ' A' ' 68' ' ' LEU . 0.9 OUTLIER -89.43 158.9 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.589 -0.893 . . . . 1.34 108.589 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.547 ' CG ' ' HA2' ' A' ' 67' ' ' GLY . 4.2 mtpt -160.84 130.92 5.08 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.106 -1.038 . . . . 1.85 110.908 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.686 HG21 ' HB2' ' A' ' 65' ' ' LEU . 85.7 t -84.75 160.75 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.533 -0.729 . . . . 0.45 109.055 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.511 ' N ' HG12 ' A' ' 77' ' ' VAL . 68.3 m -160.41 138.14 9.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.132 -0.98 . . . . 1.08 109.817 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.687 ' CE2' HD13 ' A' ' 62' ' ' ILE . 45.6 m-85 -57.69 129.39 41.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.241 -0.912 . . . . 1.48 109.205 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.704 ' HB3' ' HB2' ' A' ' 5' ' ' ASN . . . -70.04 106.98 3.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.244 -0.91 . . . . 1.16 109.954 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.481 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -121.68 159.7 49.71 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.829 . . . . 6.81 109.144 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 81' ' ' ARG . 35.6 Cg_endo -77.56 170.59 18.98 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.579 2.186 . . . . 4.36 110.441 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.1 t -48.7 161.05 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 5.61 109.386 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.558 ' O ' ' HB3' ' A' ' 85' ' ' ALA . 0.9 OUTLIER -62.42 -32.6 73.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.281 -0.887 . . . . 6.16 109.368 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . 67.58 62.82 0.43 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 6.48 109.519 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.415 ' O ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -85.25 -173.49 4.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.184 -0.947 . . . . 7.63 109.251 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.415 HD13 ' O ' ' A' ' 86' ' ' SER . 38.7 mm -142.9 -62.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.257 -0.902 . . . . 8.85 109.455 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.003 -0.999 . . . . 9.14 109.392 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.38 -0.6 . . . . 7.14 109.38 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -68.6 120.19 14.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.93 . . . . 5.46 109.43 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 55' ' ' PRO . 23.3 t -159.07 -48.8 0.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.237 -0.915 . . . . 3.49 109.617 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 61.75 89.79 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.852 . . . . 3.89 109.492 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.412 ' CG2' ' O ' ' A' ' 52' ' ' TYR . 16.7 p -118.4 71.48 0.84 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.19 -0.944 . . . . 1.93 109.43 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.857 ' C ' HD22 ' A' ' 6' ' ' LEU . 5.2 p30 -125.01 113.68 18.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 1.28 109.733 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.014 HD21 ' HB1' ' A' ' 58' ' ' ALA . 3.1 mm? -135.83 89.36 2.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.381 -0.824 . . . . 0.8 109.338 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.62 HD12 ' HE1' ' A' ' 49' ' ' PHE . 6.1 tt -92.75 127.52 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.052 -1.03 . . . . 0.56 109.305 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.543 HG12 HD21 ' A' ' 11' ' ' LEU . 21.9 t -101.27 152.05 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.321 -0.862 . . . . 0.45 109.418 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 0.8 OUTLIER -145.38 176.63 9.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.127 -0.983 . . . . 1.96 109.438 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 75' ' ' ILE . 53.0 m-85 61.15 43.77 10.75 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.332 -0.855 . . . . 1.4 109.608 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.543 HD21 HG12 ' A' ' 8' ' ' VAL . 26.5 mt -80.11 137.96 53.01 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.922 . . . . 0.56 109.462 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 15' ' ' MET . 35.9 Cg_endo -78.76 157.63 27.86 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.559 2.173 . . . . 0.7 110.428 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.464 ' NE2' ' HE2' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -45.36 -69.74 0.12 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.235 -0.915 . . . . 2.54 110.198 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.48 ' OD1' ' OE2' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -38.71 -48.14 1.45 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.341 -0.849 . . . . 1.42 110.715 -178.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.549 ' CA ' ' OE2' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -49.25 135.51 16.87 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.952 -1.093 . . . . 1.06 109.554 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.794 HG23 ' H ' ' A' ' 18' ' ' ASP . 5.8 t -157.89 -154.79 0.46 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.349 -0.982 . . . . 0.68 108.349 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.625 ' N ' HG23 ' A' ' 16' ' ' THR . 9.2 tt0 -67.1 -30.32 70.31 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.754 -1.216 . . . . 2.51 110.128 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.794 ' H ' HG23 ' A' ' 16' ' ' THR . 0.9 OUTLIER -84.5 -47.12 10.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.98 -1.075 . . . . 1.28 109.896 -179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.549 ' OE2' ' CA ' ' A' ' 15' ' ' MET . 6.5 tt0 -71.99 -15.52 62.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.025 -1.047 . . . . 1.59 109.265 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.639 ' HB2' HD12 ' A' ' 35' ' ' LEU . 13.5 t80 -86.66 -31.8 20.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.158 -0.964 . . . . 1.21 108.913 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -70.04 -54.16 14.38 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.453 -0.779 . . . . 2.4 109.639 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 p -61.76 -44.81 96.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.247 -0.908 . . . . 1.2 109.906 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.783 HD12 ' CD1' ' A' ' 24' ' ' PHE . 1.4 tm? -48.45 -66.96 0.32 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.201 -0.937 . . . . 0.8 109.716 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.783 ' CD1' HD12 ' A' ' 23' ' ' LEU . 28.3 m-85 -84.38 6.23 24.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.175 -0.953 . . . . 1.26 109.73 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.11 -36.66 12.53 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.794 -1.322 . . . . 0.49 109.794 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.7 m -90.02 42.64 1.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -1.202 . . . . 1.68 109.662 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 1.01 ' CD1' HD11 ' A' ' 65' ' ' LEU . 13.0 mt -141.2 -39.08 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 0.93 109.514 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -163.56 162.11 34.69 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.75 -1.34 . . . . 0.84 109.75 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 31' ' ' GLU . 10.3 t70 -74.04 83.11 1.76 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.294 -1.121 . . . . 2.21 109.582 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.743 HG21 ' SG ' ' A' ' 33' ' ' CYS . 13.4 mt -55.11 90.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.197 -0.94 . . . . 0.64 109.156 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 29' ' ' ASP . 6.4 mm-40 -37.11 -29.66 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.787 -0.57 . . . . 2.34 110.134 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 30' ' ' ILE . 0.6 OUTLIER -172.65 115.7 0.3 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.126 -0.984 . . . . 1.45 109.807 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.743 ' SG ' HG21 ' A' ' 30' ' ' ILE . 3.8 m -89.36 171.94 9.38 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.324 -0.86 . . . . 0.85 108.699 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.41 71.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.01 -1.057 . . . . 2.59 109.983 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 1.043 HD23 ' N ' ' A' ' 36' ' ' VAL . 7.2 tt -68.78 152.32 45.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.95 109.619 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.043 ' N ' HD23 ' A' ' 35' ' ' LEU . 54.2 t -68.02 126.06 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.83 109.479 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 38' ' ' ASP . 3.2 tpt85 -149.58 93.99 2.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 4.91 109.445 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 38' ' ' ASP . 0.5 OUTLIER -43.71 161.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 3.19 109.496 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.71 20.35 18.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.267 -0.896 . . . . 6.06 109.419 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 41' ' ' THR . 39.8 mt -111.72 -91.65 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.867 . . . . 4.66 109.326 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.562 HG23 ' N ' ' A' ' 42' ' ' GLY . 5.7 t -77.87 -46.75 20.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.225 -0.922 . . . . 6.18 109.104 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.562 ' N ' HG23 ' A' ' 41' ' ' THR . . . 116.88 28.56 2.43 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.681 -1.368 . . . . 3.99 109.681 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.34 136.37 36.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -1.153 . . . . 5.77 109.518 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.8 p -79.31 146.79 32.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.887 . . . . 3.48 109.538 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.861 HD12 HG11 ' A' ' 36' ' ' VAL . 15.8 mt -85.37 -3.27 58.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -0.878 . . . . 1.64 109.828 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 47' ' ' TYR . . . 87.63 32.34 13.52 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.91 -1.276 . . . . 0.56 109.91 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.923 ' CZ ' HG21 ' A' ' 36' ' ' VAL . 10.3 p90 -179.09 143.56 0.21 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.238 -1.154 . . . . 1.43 109.339 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.445 ' CA ' ' HA ' ' A' ' 35' ' ' LEU . . . -129.03 178.95 16.98 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.076 -1.21 . . . . 0.66 110.076 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.62 ' HE1' HD12 ' A' ' 7' ' ' ILE . 28.4 m-85 -121.23 142.68 49.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.382 -1.069 . . . . 1.43 109.134 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.645 HG13 HG23 ' A' ' 30' ' ' ILE . 32.3 t -144.16 142.09 24.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.119 -0.988 . . . . 0.5 109.657 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -129.27 113.34 14.89 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.751 -0.833 . . . . 2.07 108.751 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.627 ' HE1' HG11 ' A' ' 50' ' ' VAL . 3.5 m-30 -79.01 177.42 8.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.135 -0.978 . . . . 1.23 109.398 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 t -89.76 -32.58 16.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 1.38 109.54 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.483 ' HB3' ' HD2' ' A' ' 55' ' ' PRO . 1.0 OUTLIER -129.17 161.77 56.36 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 1.9 109.5 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 54' ' ' ASP . 35.1 Cg_endo -76.78 -21.05 12.96 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.659 2.239 . . . . 0.72 110.467 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.478 ' HA ' ' OD2' ' A' ' 59' ' ' ASP . 7.6 m120 -75.57 -42.36 52.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.306 -0.871 . . . . 1.86 109.293 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -73.49 -24.59 60.2 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.374 -0.829 . . . . 1.98 109.042 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 1.014 ' HB1' HD21 ' A' ' 6' ' ' LEU . . . -77.32 -41.3 41.13 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.359 -0.838 . . . . 0.4 109.311 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 60' ' ' LYS . 17.4 p30 -69.68 -20.77 63.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.166 -0.959 . . . . 1.22 109.291 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.525 ' HG3' ' N ' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -79.29 -38.47 35.29 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.139 -0.975 . . . . 1.87 108.548 179.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.735 ' O ' HD12 ' A' ' 65' ' ' LEU . . . -65.94 -21.66 66.44 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.08 -1.012 . . . . 0.54 108.305 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.687 HD13 ' CE2' ' A' ' 79' ' ' TYR . 49.5 mt -92.86 -27.18 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.541 -0.724 . . . . 0.43 109.378 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.508 ' OD1' ' HA ' ' A' ' 60' ' ' LYS . 0.9 OUTLIER -81.11 2.61 26.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.898 -1.126 . . . . 1.56 109.537 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.7 m -133.29 -31.58 1.23 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 1.52 110.118 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.01 HD11 ' CD1' ' A' ' 27' ' ' ILE . 1.1 mt -106.9 8.19 30.49 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.047 -1.033 . . . . 1.17 110.021 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 62' ' ' ILE . 16.4 t-20 -83.18 85.78 7.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.913 -1.117 . . . . 1.81 109.408 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.547 ' HA2' ' CG ' ' A' ' 76' ' ' LYS . . . 108.8 57.85 0.55 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.123 -1.591 . . . . 0.65 109.123 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.931 ' HB2' HG23 ' A' ' 75' ' ' ILE . 2.3 mt -90.44 135.76 33.49 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.183 -1.186 . . . . 0.75 108.672 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -90.83 148.23 22.65 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.921 -1.112 . . . . 3.2 110.043 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 73' ' ' LYS . 3.9 mt -123.14 174.12 7.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.417 -0.802 . . . . 1.53 109.256 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.441 ' C ' HG23 ' A' ' 72' ' ' THR . 9.3 tt0 -56.39 -32.49 64.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 3.43 109.786 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.441 HG23 ' C ' ' A' ' 71' ' ' GLN . 73.7 p -154.56 21.42 0.47 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.172 -0.955 . . . . 1.85 109.914 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.464 ' HE2' ' NE2' ' A' ' 13' ' ' GLN . 6.5 mttp -142.84 170.63 15.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.126 -0.984 . . . . 3.18 109.504 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.2 m -129.42 108.19 10.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.198 -0.939 . . . . 0.83 109.53 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.931 HG23 ' HB2' ' A' ' 68' ' ' LEU . 0.9 OUTLIER -89.43 158.9 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.589 -0.893 . . . . 1.34 108.589 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.547 ' CG ' ' HA2' ' A' ' 67' ' ' GLY . 4.2 mtpt -160.84 130.92 5.08 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.106 -1.038 . . . . 1.85 110.908 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.686 HG21 ' HB2' ' A' ' 65' ' ' LEU . 85.7 t -84.75 160.75 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.533 -0.729 . . . . 0.45 109.055 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.511 ' N ' HG12 ' A' ' 77' ' ' VAL . 68.3 m -160.41 138.14 9.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.132 -0.98 . . . . 1.08 109.817 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.687 ' CE2' HD13 ' A' ' 62' ' ' ILE . 45.6 m-85 -57.69 129.39 41.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.241 -0.912 . . . . 1.48 109.205 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.704 ' HB3' ' HB2' ' A' ' 5' ' ' ASN . . . -70.04 106.98 3.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.244 -0.91 . . . . 1.16 109.954 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.481 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -121.68 159.7 49.71 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.829 . . . . 6.81 109.144 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 81' ' ' ARG . 35.6 Cg_endo -77.56 170.59 18.98 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.579 2.186 . . . . 4.36 110.441 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.1 t -48.7 161.05 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 5.61 109.386 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.558 ' O ' ' HB3' ' A' ' 85' ' ' ALA . 0.9 OUTLIER -62.42 -32.6 73.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.281 -0.887 . . . . 6.16 109.368 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 84' ' ' SER . . . 67.58 62.82 0.43 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 6.48 109.519 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.415 ' O ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -85.25 -173.49 4.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.184 -0.947 . . . . 7.63 109.251 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.415 HD13 ' O ' ' A' ' 86' ' ' SER . 38.7 mm -142.9 -62.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.257 -0.902 . . . . 8.85 109.455 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.003 -0.999 . . . . 9.14 109.392 179.934 . . . . . . . . 1 1 . 1 stop_ save_